{"DataElement":{"publicId":"4791549","version":"1","preferredName":"Treatment Cohort Study 9008 Code","preferredDefinition":"The code that represents the information pertaining to protocol 9008 in which subsets of a defined population are identified.","longName":"TX_COH_SDY_9008_CD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"2497526","version":"1","preferredName":"Treatment Cohort Study","preferredDefinition":"Information pertaining to studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"TX_COHORT_STDY","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2416951","version":"1","preferredName":"Therapy","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"02DBEE3F-243E-103A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-10-12","modifiedBy":"ONEDATA","dateModified":"2005-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2497524","version":"1","preferredName":"Cohort Study","preferredDefinition":"Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"C15208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort Study","conceptCode":"C15208","definition":"A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FC9E-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"ONEDATA","dateModified":"2006-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FCAF-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"SOKKERL","dateModified":"2017-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4791536","version":"1","preferredName":"9008 Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic._A system of numbered categories for representation of data.","longName":"9008_COH_CODE","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"SEVER DL-1","valueDescription":"SEVER DL-1 = Depsipeptide: 3.5 mg/m2 IV over 4 hours on days 1, 8 and 15","ValueMeaning":{"publicId":"4791541","version":"1","preferredName":"SEVER DL-1 = Depsipeptide: 3.5 mg/m2 IV over 4 hours on days 1, 8 and 15","longName":"4791541","preferredDefinition":"SEVER DL-1 = Depsipeptide: 3.5 mg/m2 IV over 4 hours on days 1, 8 and 15","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13B28949-6308-9492-E050-BB89AD431C69","latestVersionIndicator":"Yes","beginDate":"2015-04-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13B28949-6321-9492-E050-BB89AD431C69","beginDate":"2015-04-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-14","modifiedBy":"ONEDATA","dateModified":"2015-04-14","deletedIndicator":"No"},{"value":"MODER DL3","valueDescription":"MODER DL3 = Depsipeptide: 14 mg/m2 IV over 4 hours on days 1, 8 and 15","ValueMeaning":{"publicId":"4791542","version":"1","preferredName":"MODER DL3 = Depsipeptide: 14 mg/m2 IV over 4 hours on days 1, 8 and 15","longName":"4791542","preferredDefinition":"MODER DL3 = Depsipeptide: 14 mg/m2 IV over 4 hours on days 1, 8 and 15","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13B28949-632B-9492-E050-BB89AD431C69","latestVersionIndicator":"Yes","beginDate":"2015-04-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13B28949-6344-9492-E050-BB89AD431C69","beginDate":"2015-04-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-14","modifiedBy":"ONEDATA","dateModified":"2015-04-14","deletedIndicator":"No"},{"value":"MODER DL2","valueDescription":"MODER DL2 = Depsipeptide: 10 mg/m2 IV over 4 hours on days 1, 8 and 15","ValueMeaning":{"publicId":"4791543","version":"1","preferredName":"MODER DL2 = Depsipeptide: 10 mg/m2 IV over 4 hours on days 1, 8 and 15","longName":"4791543","preferredDefinition":"MODER DL2 = Depsipeptide: 10 mg/m2 IV over 4 hours on days 1, 8 and 15","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13B28949-634E-9492-E050-BB89AD431C69","latestVersionIndicator":"Yes","beginDate":"2015-04-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13B28949-6367-9492-E050-BB89AD431C69","beginDate":"2015-04-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-14","modifiedBy":"ONEDATA","dateModified":"2015-04-14","deletedIndicator":"No"},{"value":"MODER DL1","valueDescription":"MODER DL1 = Depsipeptide: 7 mg/m2 IV over 4 hours on days 1, 8 and 15","ValueMeaning":{"publicId":"4791544","version":"1","preferredName":"MODER DL1 = Depsipeptide: 7 mg/m2 IV over 4 hours on days 1, 8 and 15","longName":"4791544","preferredDefinition":"MODER DL1 = Depsipeptide: 7 mg/m2 IV over 4 hours on days 1, 8 and 15","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13B28949-6371-9492-E050-BB89AD431C69","latestVersionIndicator":"Yes","beginDate":"2015-04-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13B28949-638A-9492-E050-BB89AD431C69","beginDate":"2015-04-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-14","modifiedBy":"ONEDATA","dateModified":"2015-04-14","deletedIndicator":"No"},{"value":"MODER DL-1","valueDescription":"MODER DL-1 = Depsipeptide: 5 mg/m2 IV over 4 hours on days 1, 8 and 15","ValueMeaning":{"publicId":"4791545","version":"1","preferredName":"MODER DL-1 = Depsipeptide: 5 mg/m2 IV over 4 hours on days 1, 8 and 15","longName":"4791545","preferredDefinition":"MODER DL-1 = Depsipeptide: 5 mg/m2 IV over 4 hours on days 1, 8 and 15","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13B28949-6394-9492-E050-BB89AD431C69","latestVersionIndicator":"Yes","beginDate":"2015-04-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13B28949-63AD-9492-E050-BB89AD431C69","beginDate":"2015-04-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-14","modifiedBy":"ONEDATA","dateModified":"2015-04-14","deletedIndicator":"No"},{"value":"MILD DL1","valueDescription":"MILD DL1 = Depsipeptide: 14 mg/m2 IV over 4 hours on days 1, 8 and 15","ValueMeaning":{"publicId":"4791546","version":"1","preferredName":"MILD DL1 = Depsipeptide: 14 mg/m2 IV over 4 hours on days 1, 8 and 15","longName":"4791546","preferredDefinition":"MILD DL1 = Depsipeptide: 14 mg/m2 IV over 4 hours on days 1, 8 and 15","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13B28949-63B7-9492-E050-BB89AD431C69","latestVersionIndicator":"Yes","beginDate":"2015-04-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13B28949-63D0-9492-E050-BB89AD431C69","beginDate":"2015-04-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-14","modifiedBy":"ONEDATA","dateModified":"2015-04-14","deletedIndicator":"No"},{"value":"MILD DL-1","valueDescription":"MILD DL-1 = Depsipeptide: 10 mg/m2 IV over 4 hours on days 1, 8 and 15","ValueMeaning":{"publicId":"4791547","version":"1","preferredName":"MILD DL-1 = Depsipeptide: 10 mg/m2 IV over 4 hours on days 1, 8 and 15","longName":"4791547","preferredDefinition":"MILD DL-1 = Depsipeptide: 10 mg/m2 IV over 4 hours on days 1, 8 and 15","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13B28949-63DA-9492-E050-BB89AD431C69","latestVersionIndicator":"Yes","beginDate":"2015-04-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13B28949-63F3-9492-E050-BB89AD431C69","beginDate":"2015-04-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-14","modifiedBy":"ONEDATA","dateModified":"2015-04-14","deletedIndicator":"No"},{"value":"NORMAL DL1","valueDescription":"NORMAL DL1 = Depsipeptide: 14 mg/m2 IV over 4 hours on days 1, 8 and 15","ValueMeaning":{"publicId":"4791548","version":"1","preferredName":"NORMAL DL1 = Depsipeptide: 14 mg/m2 IV over 4 hours on days 1, 8 and 15","longName":"4791548","preferredDefinition":"NORMAL DL1 = Depsipeptide: 14 mg/m2 IV over 4 hours on days 1, 8 and 15","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13B28949-63FD-9492-E050-BB89AD431C69","latestVersionIndicator":"Yes","beginDate":"2015-04-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13B28949-6416-9492-E050-BB89AD431C69","beginDate":"2015-04-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-14","modifiedBy":"ONEDATA","dateModified":"2015-04-14","deletedIndicator":"No"},{"value":"SEVERE DL1","valueDescription":"SEVERE DL1 = Depsipeptide: 5 mg/m2 IV over 4 hours on days 1, 8 and 15","ValueMeaning":{"publicId":"5095432","version":"1","preferredName":"SEVERE DL1 = Depsipeptide: 5 mg/m2 IV over 4 hours on days 1, 8 and 15","longName":"5095432","preferredDefinition":"SEVERE DL1 = Depsipeptide: 5 mg/m2 IV over 4 hours on days 1, 8 and 15","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2823CFFF-4EA0-9357-E050-BB89AD436969","latestVersionIndicator":"Yes","beginDate":"2015-12-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2015-12-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2823CFFF-4EB9-9357-E050-BB89AD436969","beginDate":"2015-04-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2015-12-30","modifiedBy":"ONEDATA","dateModified":"2015-12-30","deletedIndicator":"No"},{"value":"SEVERE DL2","valueDescription":"SEVERE DL2 = Depsipeptide: 7 mg/m2 IV over 4 hours on days 1, 8 and 15","ValueMeaning":{"publicId":"5095433","version":"1","preferredName":"SEVERE DL2 = Depsipeptide: 7 mg/m2 IV over 4 hours on days 1, 8 and 15","longName":"5095433","preferredDefinition":"SEVERE DL2 = Depsipeptide: 7 mg/m2 IV over 4 hours on days 1, 8 and 15","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2823CFFF-4EC3-9357-E050-BB89AD436969","latestVersionIndicator":"Yes","beginDate":"2015-12-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2015-12-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2823CFFF-4EDC-9357-E050-BB89AD436969","beginDate":"2015-04-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2015-12-30","modifiedBy":"ONEDATA","dateModified":"2015-12-30","deletedIndicator":"No"},{"value":"SEVERE DL3","valueDescription":"SEVERE DL3 = Depsipeptide: 10 mg/m2 IV over 4 hours on days 1, 8 and 15","ValueMeaning":{"publicId":"5095434","version":"1","preferredName":"SEVERE DL3 = Depsipeptide: 10 mg/m2 IV over 4 hours on days 1, 8 and 15","longName":"5095434","preferredDefinition":"SEVERE DL3 = Depsipeptide: 10 mg/m2 IV over 4 hours on days 1, 8 and 15","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2823CFFF-4EE6-9357-E050-BB89AD436969","latestVersionIndicator":"Yes","beginDate":"2015-12-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2015-12-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2823CFFF-4EFF-9357-E050-BB89AD436969","beginDate":"2015-04-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2015-12-30","modifiedBy":"ONEDATA","dateModified":"2015-12-30","deletedIndicator":"No"},{"value":"SEVERE DL4","valueDescription":"SEVERE DL4 = Depsipeptide: 14 mg/m2 IV over 4 hours on days 1, 8 and 15","ValueMeaning":{"publicId":"5095435","version":"1","preferredName":"SEVERE DL4 = Depsipeptide: 14 mg/m2 IV over 4 hours on days 1, 8 and 15","longName":"5095435","preferredDefinition":"SEVERE DL4 = Depsipeptide: 14 mg/m2 IV over 4 hours on days 1, 8 and 15","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2823CFFF-4F09-9357-E050-BB89AD436969","latestVersionIndicator":"Yes","beginDate":"2015-12-30","endDate":null,"createdBy":"MAESKEB","dateCreated":"2015-12-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2823CFFF-4F22-9357-E050-BB89AD436969","beginDate":"2015-04-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2015-12-30","modifiedBy":"ONEDATA","dateModified":"2015-12-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4386398","version":"1","preferredName":"Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic.:A system of numbered categories for representation of data.","longName":"C61512:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort","conceptCode":"C61512","definition":"A group of individuals, identified by a common characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE558C16-1C27-C6A8-E040-BB89AD430BEE","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-07-16","modifiedBy":"ONEDATA","dateModified":"2014-07-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13B28949-6268-9492-E050-BB89AD431C69","latestVersionIndicator":"Yes","beginDate":"2015-04-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-14","modifiedBy":"MAESKEB","dateModified":"2015-12-30","changeDescription":"9008_Theradex_04.14.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Please select the cohort:","type":"Preferred Question Text","description":"Please select the cohort:","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"13B28949-6420-9492-E050-BB89AD431C69","latestVersionIndicator":"Yes","beginDate":"2015-04-14","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-04-14","modifiedBy":"HARTLEYG","dateModified":"2015-04-14","changeDescription":"9008_Theradex_04.14.15_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}